Startup based in the United States, most recent round Seed.
Based in the United States, Genvax is a startup. Its most recent tracked round is Seed.
Genvax Technologies develops next-generation mRNA and nanoparticle vaccines for animal health, focusing on custom, herd-specific livestock vaccines to prevent and treat animal diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.